HemoShear Therapeutics develops new treatments for patients with rare metabolic disorders. Founded by Brett R. Blackman and Brian R. Wamhoff in 2008, HemoShear Therapeutics is backed by investors that include Janus Henderson Investors, Adage Capital Management, Suvretta Capital Management, and Jaffray Woodriff and is headquartered in Charlottesville.
FOUNDED:
2008
INDUSTRY:
Biotechnology, Health Care, Medical
FOUNDERS:
Brett R. Blackman, Brian R. Wamhoff
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
